Fluconazole prophylaxis in extremely low birth weight infants and neurodevelopmental outcomes and quality of life at 8 to 10 years of age.
about
Prophylactic systemic antifungal agents to prevent mortality and morbidity in very low birth weight infantsProphylactic systemic antifungal agents to prevent mortality and morbidity in very low birth weight infantsFluconazole prophylaxis for prevention of invasive candidiasis in infantsTreatment and prophylaxis of invasive candidiasisFluconazole pharmacokinetics and safety in premature infantsCandida parapsilosis is a significant neonatal pathogen: a systematic review and meta-analysisFluconazole Prophylaxis for the Prevention of Candidiasis in Premature Infants: A Meta-analysis Using Patient-level Data.Effect of fluconazole prophylaxis on candidiasis and mortality in premature infants: a randomized clinical trial.Neonatal infectious diseases: evaluation of neonatal sepsis.The use of ciprofloxacin and fluconazole in Italian neonatal intensive care units: a nationwide survey.Cytokine profiles of preterm neonates with fungal and bacterial sepsis.The management of Candida infections in preterm neonates and the role of micafungin.Pharmacotherapy approaches to antifungal prophylaxis.Safety of fluconazole in paediatrics: a systematic reviewInvasive fungal infections in newborns and current management strategies.Update on the management of Candida infections in preterm neonates.Therapeutic strategies for invasive fungal infections in neonatal and pediatric patients: an update.Does fluconazole prophylaxis reduce death or invasive candida infection in extremely preterm infants?Targeted fluconazole prophylaxis for high-risk very low birth weight infants.
P2860
Q24186385-21872C38-EDF2-40F0-A8D9-AAD8E54A0C60Q24197610-B601F8ED-710F-47ED-AEED-8A424BB1997FQ26995413-AC66A100-03D1-40D9-971D-4F00303D8D41Q27001567-203EAEA8-9028-4BB5-9783-C3C6380BC082Q27014816-7A2B0E13-0002-4754-A2F6-AF2E594098BDQ28533912-C1E2B485-FF8F-489F-9644-F1A48FA51323Q30276620-7375D8AB-0C96-4D7F-AB52-6A5405F77BC7Q30405312-1DB9023C-DE9D-47ED-B226-FD3A21B018D9Q34332344-CD5A7932-CE81-4B9C-A264-0119F9CD5511Q34538074-314B563B-43B9-487E-8708-669E3CD0A112Q36777033-F8FAA928-B32E-4620-B29A-1E9F3081A1C1Q37900293-14B2539F-4B70-436C-897E-940A2570DA0DQ38020238-F047003F-6A92-43A3-B3C2-DD9C84FFE166Q38074608-BA4A0F63-6C2C-416B-84FE-38EF24160DF0Q38119554-0DE3FC8B-E83C-4B12-8BCA-2A40210AEE63Q38326174-693293AE-A431-4D37-8050-A025C850A17AQ38353420-94DBC2E6-1037-46C2-B7D0-885634491DF6Q40359216-42BA340A-A154-4943-A8B8-8A9CD796E1A9Q47308131-87E7BA67-DF6E-4CBB-AE22-3D8B6B73BAF5
P2860
Fluconazole prophylaxis in extremely low birth weight infants and neurodevelopmental outcomes and quality of life at 8 to 10 years of age.
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Fluconazole prophylaxis in ext ...... life at 8 to 10 years of age.
@ast
Fluconazole prophylaxis in ext ...... life at 8 to 10 years of age.
@en
type
label
Fluconazole prophylaxis in ext ...... life at 8 to 10 years of age.
@ast
Fluconazole prophylaxis in ext ...... life at 8 to 10 years of age.
@en
prefLabel
Fluconazole prophylaxis in ext ...... life at 8 to 10 years of age.
@ast
Fluconazole prophylaxis in ext ...... life at 8 to 10 years of age.
@en
P2093
P1476
Fluconazole prophylaxis in ext ...... life at 8 to 10 years of age.
@en
P2093
Amy L Cuff
David A Kaufman
Julia B Wamstad
Leigh B Grossman
Matthew J Gurka
Peter Patrick
Robert Boyle
P304
759-765.e1
P356
10.1016/J.JPEDS.2010.11.002
P407
P577
2010-12-18T00:00:00Z